# L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)

> **NCT00677339** · PHASE3 · COMPLETED · sponsor: **Menzies School of Health Research** · enrollment: 200 (actual)

## Conditions studied

- Smear Positive Pulmonary Tuberculosis

## Interventions

- **DRUG:** L-arginine
- **DRUG:** Vitamin D
- **DRUG:** Placebo L-arginine
- **DRUG:** Placebo Vitamin D

## Key facts

- **NCT ID:** NCT00677339
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-05
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2012-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00677339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00677339, "L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00677339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*